The current regulatory controls governing the sale and supply of medicinal products are set out in the Medicinal Products (Licensing and Sale) Regulations, 1998, which replaced earlier regulations dating back to 1975. These regulations, which reflect European Community requirements on the control of medicines, require that medicinal products placed on the market in Ireland, must be the subject of a product authorisation granted by the Irish Medicines Board. However, before the board will grant such an authorisation, it must first be satisfied that the product meets criteria laid down by the European Community to establish the safety, quality and efficacy of the product. The regulations, which are directed towards ensuring the health and safety of consumers, do not make any distinction between conventional pharmaceutical products and so-called alternative medicines.